Abstract
Vascular surgeons have been able to perform complex revascularization procedures by relying on pharmacologic advances. The discovery of heparin by Jay McLean made this possible. The ability to dissolve occluding thrombus by activating the thrombolytic system with a variety of agents is currently being pursued to reestablish blood flow to an ischemic vascular bed, with the hope of achieving greater long-term clinical success and lower operative mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Taylor FB Jr, Botts J: Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen, Biochemistry 38: 1627, 1968.
Tillet WS, Garner RL: The fibrinolytic activity of hemolytic streptococci, J Exp Med 58: 485, 1933.
Tillet WS, Sherry S: The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal deoxyribonuclease on fibrinous, purulent, and sanguineous pleural exudations, J Clin Invest 28: 173, 1949.
Chesterman CN, Cederholm-Williams SA, Allington MJ: The degradation of streptokinase during the production of plasminogen activator, Thromb Res 5: 413, 1974.
Rubin RN: Choosing a thrombolytic agent in acute myocardial infarction, Pharmacol Ther 17: 617, 1992.
James DC: Antistreptokinase levels in various hospital groups, Postgrad Med 49: 26, 1973.
MacFarlane RG, Pilling J: Fibrinolytic activity in normal urine, Nature 159: 779, 1947.
Williams JRB: The fibrinolytic activity of urine, Br J Exp Pathol 32: 530–537, 1951.
Astrup T, Sterndorff I: An activator of plasminogen in normal urine, Proc Soc Exp Biol Med 81: 675, 1952.
Sobel GW, Mohler SR, Jones NW et al: Urokinase, an activator of profibnnolysin extracted from urine, Am J Physiol 171: 768–769, 1952.
Guenzler WA, Steffens GJ, Oetting F et al: The primary structure of high-molecular-mass urokinase from human urine: the complete amino acid sequence of the A chain, Hoppe-Seylers Z Physiol Chem 363: 1155, 1982.
Verstraete M: Biochemical and clinical aspects of thrombolysis, Semin Hematol 15: 35, 1978.
Ratzkin B, Lee SG, Schrenk WJ et al: Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase, Proc Natl Acad Sei USA 78: 3313–3317, 1981.
Belkin M, Belkin B, Bucknam CA et al: Intraarterial fibrinolytic therapy: efficacy of streptokinase versus urokinase, Arch Surg 121: 769, 1986.
Van Breda A, Katzen BT, Deutsch AS: Urokinase versus streptokinase in local thrombolysis, Radiology 165: 109, 1987.
Pennica D, Holmes WE, Kohr WJ et al: Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli, Nature 301: 214, 1983.
Rajput B, Degen SF, Reich et al: Chromosomal locations of human plasminogen activator and urokinase genes, Science 230: 672, 1985.
Hoylaerts M, Rijken DC, Lijnen HR et al: Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay,J Lab Clin Med 101: 274, 1983.
TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial: phase I findings, N Engl J Med 312: 932, 1985.
Gao S, Morser J, McLean K et al: Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase, Thromb Res 58: 421–433, 1990.
Clifton EE: The use of plasmin in humans, Ann NY Acad Sei 68: 209–229, 1957.
Dotter CT, Rosch J, Seaman AJ et al: Streptokinase treatment of thromboembolic disease, Radiology 102: 283–290, 1972.
Dotter CT, Rosch J, Seaman AJ: Selective clot lysis with low dose streptokinase, Radiology 111: 31–37, 1974.
Ouriel K, Shortell CK, DeWeese JA et al: A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral ischemia,/Vase Surg 19: 1021–1030, 1994.
Jivegard L, Holm J, Shersten T: The outcome in arterial thrombosis misdiagnosed as arterial embolism, Acta Chir Scand 152: 251–256, 1986.
Plecha FR, Poires WJ: Intraoperative angiography in the immediate assessment of arterial reconstruction, Arch Surg 105: 902–907, 1972.
White GH, White RA, Kopchok GE et al: Angio-scopic thromboembolectomy; preliminary observation with a recent technique, J Vase Surg 7: 318–325, 1988.
Blaisdell FW, Steele M, Allen RE: Management of acute lower extremity arterial ischemia due to embolism and thrombosis, Surgery 84: 822–834, 1978.
Jivegard L, Holm J, Shersten T: Acute limb ischemia due to arterial embolism or thrombosis,/Cardiovasc Surg 29: 32–36, 1988.
McNamara TO, Bomberger RA, Merchant RF: Intra-arterial urokinase as the initial therapy for acutely ischemic lower limbs, Circulation 83 (suppl 1): 106–119, 1991.
Rutherford RB, Flanigan DP, Gupta SK et al: Suggested standards for reports dealing with lower extremity ischemia, J Vase Surg 4: 80–94, 1986.
Ricotta J: Intra-arterial thrombolysis: a surgical view, Circulation 83 (suppl 1): 120–121, 1991.
The STILE Investigators: Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE Trial, Ann Surg 220: 251–268, 1994.
Shortell CK, Ouriel K: Thrombolysis in acute peripheral arterial occlusion: predictors of immediate success, Ann Vase Surg 8: 59–65, 1994.
Ouriel K, Veith FJ, Sasahara A A: Thrombolysis or peripheral arterial surgery: phase I results, J Vase Surg 23: 64–73, 1996.
Ouriel K, Veith FJ, Sasahara AA et al: A comparison of recombinant urokinase with vascular surgery as the initial treatment for acute arterial occlusion of the legs, N Engl J Med 338: 1105–1111, 1998.
Hoylaerts M, Jijken DC, Lijnen HR, Collen D: Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin,/Biol Chem 257: 2912–2919, 1982.
Strieker RB, Wong D, Tak Shiu D et al: Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation, Blood 68: 275–280, 1986.
DeMunk GAW, Caspers MPM, Chang GTG et al: Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments, Biochemistry 28: 7318–7325, 1989.
Pannell R, Gurewich V: Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect, Blood 67: 1215–1223, 1986.
Mills JL, Harris EJ, Taylor LM et al: The importance of routine surveillance of distal bypass grafts with duplex scanning: a study of 379 reverse vein grafts, Vase Surg 12: 379–389, 1990.
Quinones-Balrich WJ, Prego A, Ucelay-Gomez R et al: Failure of PTFE infrainguinal revascularization: patterns, management, alternatives, and outcome, Ann Vase Surg 5: 163–169, 1991.
Seabrook DF, Mewissen MW, Schmitt DD et al: Percutaneous intra-arterial thrombolysis in the treatment of thrombosis of lower extremity arterial reconstruction,/Vase Surg 13: 646–651, 1991.
Gardiner GA, Harrington DP, Koltun W et al: Salvage of occluded arterial bypass grafts by means of thrombolysis, J Vase Surg 13: 646–651, 1991.
Sullivan KL, Gardiner GA, Kandarpa K et al: Efficacy of thrombolysis in infrainguinal bypass grafts, Circulation 83 (suppl 1): 99–105, 1991.
Green RM, Ouriel K, Ricotta JJ et al: Revision of failed infrainguinal bypass grafts: principles of management, Surgery 100: 646–653, 1986.
Hye RJ, Turner C, Valji K et al: Is thrombolysis of occluded popliteal and tibial bypass grafts worthwhile? J Vase Surg 20: 588–597, 1994.
Garcia R, Saroyan RM, Senkowsky J et al: Intraoperative intra-arterial urokinase infusion as an adjunct to Fogarty catheter embolectomy in acute arterial occlusion, Surg Gynecol Obstet 171: 971–978, 1990.
Quinones-Balrich WJ, Ziomek S, Henderson TC et al: Intraoperative fibrinolytic therapy: experimental evaluation, J Vase Surg 4: 229–236, 1986.
Bevilacqua MP, Gimbrone: Inducible endothelial functions in inflammation and coagulation, Semin Thromb Hemost 13: 425–433, 1987.
Jacobs GR, Reinisch JF, Puckett C: Microvascular fibrinolysis after ischemia: its relation to vascular patency and tissue survival, Blast Reconstr Surg 68: 737–741, 1981.
Belkin M, Valeri R, Hobson RW: Intraarterial urokinase increases skeletal muscle viability after acute ischemia, J Vase Surg 9: 161–168, 1989.
Norem RF, Short DH, Kerstein MD: Role òf intraoperative fibrinolytic therapy in acute arterial occlusion, Surg Gynecol Obstet 167: 87–91, 1988.
Quinones-Balrich WJ, Baker JD, Busuttil RW et al: Intraoperative infusion of lytic drugs for thrombotic complications of revascularization, J Vase Surg 10: 408–417, 1989.
Comerota A J, White JV: Intraoperative, intraarterial thrombolytic therapy as an adjunct to revascularization in patients with residual and distal arterial thrombus, Semin Vase Surg 5: 110–117, 1992.
Comerota A J, White JV, Grosch JD: Intraoperative, intra-arterial thrombolytic therapy for salvage of limbs in patients with distal arterial thrombosis, Surg Gynecol Obstet 169: 283–289, 1989.
Comerota AJ, Rao AK, Throm RC et al: A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularizations: regional and systemic effects, Ann Surg 218: 534, 1993.
Thompson SG, Kienest J, Pyke SDM et al: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, New Engl J Med 332: 635–641, 1995.
Williams NS: Treatment of asymptomatic popliteal aneurysm: protection at a price, Br J Surg 79: 731–732, 1992.
Gifford RW, Hines EA, James EA: An analysis and follow-up study of 100 popliteal aneurysms, Surgery 84: 775–783, 1953.
Dawson I, van Bockel H, Brand R et al: Popliteal artery aneurysms: long term follow-up of aneurysmal disease and results of surgical management, J Vase Surg 13: 398–407, 1991.
Bouhoutsos J, Martin P: Popliteal aneurysms: a review of 116 cases, Br J Surg 61: 469–475, 1974.
Shortell CK, DeWeese JA, Ouriel K et al: Popliteal artery aneurysms: a 25 year experience, J Vase Surg 14: 771–779, 1991.
Cotton LT, Flute PT, Tsapogas MJC: Popliteal artery thrombosis treated with streptokinase, Lancet ii: 1081–1083, 1962.
Schwartz W, Berkowitz H, Taormina V et al: The preoperative use of intra-arterial thrombolysis for a thrombosed popliteal artery aneurysm, J Cardiovasc Surg 25: 465–468, 1984.
Ferguson LJ, Faris I, Robertson A et al: Intraarterial streptokinase therapy to relieve acute limb ischemia, J Vase Surg 4: 205–210, 1986.
Carpenter JP, Barker CF, Roberts B et al: Popliteal artery aneurysms: current management and outcome, J Vase Surg 19: 65–73, 1994.
Varga ZA, Locke-Edmunds JC, Baird RN et al: A multicenter study of popliteal aneurysms, J Vase Surg 20: 171–177, 1994.
Galland RB, Earnshaw JJ, Baird RN et al: Acute limb deterioration during intra-arterial thrombolysis, Br J Surg 80: 1118–1120, 1993.
Thompson JF, Beard J, Scott DJA et al: Intraoperative thrombolysis in the management of thrombosed popliteal aneurysm, Br J Surg 80: 858–859, 1993.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Donayre, C.E., Ouriel, K. (1999). Thrombolysis: Peripheral Arterial Applications. In: White, R.A., Fogarty, T.J. (eds) Peripheral Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3105-7_32
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3105-7_32
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3107-1
Online ISBN: 978-1-4757-3105-7
eBook Packages: Springer Book Archive